Peptides for menopause bloating: what the evidence actually says

What did @sally.swalling actually say?

Honestly, not much. The transcript is a single motivational line: "Girl, you have no idea how amazing life is about to get for you. Stay focused and trust the process." That's it. The actual claim lives in the visual, the caption, and the affiliate code, not the words. The caption shows a photo she describes as severe bloating during menopause, tags Alpha Peptides Australia, and drops a discount code. So the implicit claim is: peptides fixed her menopause bloating, and they can fix yours too.

That's worth examining carefully, because a before-and-after image paired with an affiliate code is a commercial claim, even when the spoken words are vague enough to avoid liability. The "trust the process" framing also does something specific: it discourages the skepticism you should absolutely have before spending money on unregulated peptide products.

Does the science back this up?

There is no peer-reviewed evidence that any peptide supplement sold by Australian wellness brands reliably reduces menopause-related bloating. That's not a technicality. It's a gap in the research. Menopause bloating has real, studied causes, including estrogen withdrawal, slowed gut motility, and changes in the gut microbiome (Paine et al., 2017, Menopause). None of those mechanisms have been addressed in randomized controlled trials using retail peptide products.

Some peptides used in clinical research, BPC-157 in particular, have shown gastrointestinal effects in animal models. Sikiric et al. (2018, Current Pharmaceutical Design) documented mucosal healing properties in rodent gut studies. But animal data does not translate directly to human outcomes, and it certainly doesn't translate to a capsule or powder sold with a discount code. The jump from "BPC-157 shows promise in rat intestinal injury models" to "this fixed my menopause bloating" is not supported.

What did they get wrong (or right)?

To be fair: the bloating she shows is real, menopause-related GI symptoms are real, and they are genuinely undertreated by conventional medicine. Women are routinely dismissed when they report these symptoms. That frustration is legitimate and her experience deserves to be taken seriously.

What she got wrong is the implied causation. Showing a bloated abdomen, then promoting a peptide brand, creates a before-and-after narrative without any evidence that the peptides caused the improvement. Menopause symptoms fluctuate. Bloating resolves for many reasons, including dietary changes, hormonal shifts, stress reduction, or just time. Without a controlled comparison, attributing the change to peptides is speculation presented as fact.

The affiliate code makes this worse. She has a financial incentive to attribute her improvement to this specific product. That doesn't mean she's lying, but it does mean her testimony is not neutral evidence.

What should you actually know?

If you're experiencing severe bloating during perimenopause or menopause, there are evidence-based options worth discussing with a clinician before spending money on peptides. Hormone therapy, specifically low-dose estradiol, has documented effects on gut motility and bloating in menopausal women (Rao et al., 2010, American Journal of Gastroenterology). Dietary interventions targeting fermentable carbohydrates (the low-FODMAP approach) have strong randomized trial support for functional bloating (Gibson & Shepherd, 2010, Journal of Gastroenterology and Hepatology).

Peptide therapy is an active research area, and some peptides may eventually prove useful for GI symptoms. But "eventually may prove useful" and "buy this with my code" are very different claims. Retail peptide products sold in Australia are largely unregulated, dosing is inconsistent, and purity is not guaranteed. If you're going to explore peptide therapy, do it through a licensed telehealth provider who can order lab work and monitor outcomes, not through a TikTok affiliate link.